MarketBeat Instant News Alerts 2 hours agoCanaccord Genuity Group Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock PriceMarketBeatCanaccord Genuity Group dropped their price objective on shares of Vertex Pharmaceuticals from $424.00 to $411.00 and set a "hold" rating for the company in a report on Wednesday.NASDAQ:VRTXRead Canaccord Genuity Group Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price2 hours agoNeedham & Company LLC Cuts Viridian Therapeutics (NASDAQ:VRDN) Price Target to $34.00MarketBeatNeedham & Company LLC decreased their target price on shares of Viridian Therapeutics from $36.00 to $34.00 and set a "buy" rating for the company in a research report on Wednesday.NASDAQ:VRDNRead Needham & Company LLC Cuts Viridian Therapeutics (NASDAQ:VRDN) Price Target to $34.002 hours agoVertex (NASDAQ:VERX) Price Target Lowered to $40.00 at Needham & Company LLCMarketBeatNeedham & Company LLC reduced their target price on Vertex from $60.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday.NASDAQ:VERXRead Vertex (NASDAQ:VERX) Price Target Lowered to $40.00 at Needham & Company LLC2 hours agoDA Davidson Forecasts Strong Price Appreciation for Sterling Infrastructure (NASDAQ:STRL) StockMarketBeatDA Davidson upped their price target on Sterling Infrastructure from $265.00 to $355.00 and gave the stock a "buy" rating in a report on Wednesday.NASDAQ:STRLRead DA Davidson Forecasts Strong Price Appreciation for Sterling Infrastructure (NASDAQ:STRL) Stock2 hours agoCanaccord Genuity Group Has Lowered Expectations for Neuronetics (NASDAQ:STIM) Stock PriceMarketBeatCanaccord Genuity Group decreased their target price on shares of Neuronetics from $8.00 to $7.00 and set a "buy" rating on the stock in a report on Wednesday.NASDAQ:STIMRead Canaccord Genuity Group Has Lowered Expectations for Neuronetics (NASDAQ:STIM) Stock Price2 hours agoSTAAR Surgical (NASDAQ:STAA) Given New $28.00 Price Target at Canaccord Genuity GroupMarketBeatCanaccord Genuity Group increased their target price on shares of STAAR Surgical from $20.00 to $28.00 and gave the stock a "hold" rating in a report on Wednesday.NASDAQ:STAARead STAAR Surgical (NASDAQ:STAA) Given New $28.00 Price Target at Canaccord Genuity Group Trending News1Archer Aviation (ACHR) to Release Quarterly Earnings on Monday2SoundHound AI (NASDAQ:SOUN) Stock Price Down 3.3% - Here's Why3CRISPR Therapeutics (NASDAQ:CRSP) Posts Quarterly Earnings Results4QuantumScape (NYSE:QS) Shares Gap Up - Still a Buy?5Federated Hermes Inc. Has $5.93 Million Stake in Virgin Galactic Holdings, Inc. (NYSE:SPCE)6Archer Aviation (NYSE:ACHR) Trading Down 4% - Here's Why7Archer Aviation (NYSE:ACHR) Shares Up 4.1% Following Analyst Upgrade8Archer Aviation (NYSE:ACHR) Stock Price Down 2.2% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoDA Davidson Forecasts Strong Price Appreciation for Qualys (NASDAQ:QLYS) StockMarketBeatNASDAQ:QLYSRead DA Davidson Forecasts Strong Price Appreciation for Qualys (NASDAQ:QLYS) Stock2 hours agoDA Davidson Forecasts Strong Price Appreciation for Primoris Services (NASDAQ:PRIM) StockMarketBeatNASDAQ:PRIMRead DA Davidson Forecasts Strong Price Appreciation for Primoris Services (NASDAQ:PRIM) Stock2 hours agoPayoneer Global (NASDAQ:PAYO) Price Target Raised to $10.00MarketBeatNASDAQ:PAYORead Payoneer Global (NASDAQ:PAYO) Price Target Raised to $10.002 hours agoCanaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) StockMarketBeatNASDAQ:MDGLRead Canaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock2 hours agoBTIG Research Cuts OrthoPediatrics (NASDAQ:KIDS) Price Target to $39.00MarketBeatNASDAQ:KIDSRead BTIG Research Cuts OrthoPediatrics (NASDAQ:KIDS) Price Target to $39.002 hours agoDA Davidson Cuts Ichor (NASDAQ:ICHR) Price Target to $35.00MarketBeatNASDAQ:ICHRRead DA Davidson Cuts Ichor (NASDAQ:ICHR) Price Target to $35.002 hours agoCanaccord Genuity Group Issues Positive Forecast for Hillman Solutions (NASDAQ:HLMN) Stock PriceMarketBeatNASDAQ:HLMNRead Canaccord Genuity Group Issues Positive Forecast for Hillman Solutions (NASDAQ:HLMN) Stock Price2 hours agoEvolus (NASDAQ:EOLS) Price Target Cut to $18.00 by Analysts at BTIG ResearchMarketBeatNASDAQ:EOLSRead Evolus (NASDAQ:EOLS) Price Target Cut to $18.00 by Analysts at BTIG Research2 hours agoTD Cowen Forecasts Strong Price Appreciation for Addus HomeCare (NASDAQ:ADUS) StockMarketBeatNASDAQ:ADUSRead TD Cowen Forecasts Strong Price Appreciation for Addus HomeCare (NASDAQ:ADUS) Stock2 hours agoTD Cowen Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) StockMarketBeatNASDAQ:ADPTRead TD Cowen Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock2 hours agoDA Davidson Boosts Axcelis Technologies (NASDAQ:ACLS) Price Target to $90.00MarketBeatNASDAQ:ACLSRead DA Davidson Boosts Axcelis Technologies (NASDAQ:ACLS) Price Target to $90.002 hours agoCanaccord Genuity Group Issues Positive Forecast for Zeta Global (NYSE:ZETA) Stock PriceMarketBeatNYSE:ZETARead Canaccord Genuity Group Issues Positive Forecast for Zeta Global (NYSE:ZETA) Stock Price2 hours agoSally Beauty (NYSE:SBH) Price Target Raised to $15.00 at Canaccord Genuity GroupMarketBeatNYSE:SBHRead Sally Beauty (NYSE:SBH) Price Target Raised to $15.00 at Canaccord Genuity Group2 hours agoJefferies Financial Group Cuts Ringcentral (NYSE:RNG) Price Target to $29.00MarketBeatNYSE:RNGRead Jefferies Financial Group Cuts Ringcentral (NYSE:RNG) Price Target to $29.002 hours agoKlaviyo (NYSE:KVYO) Price Target Raised to $46.00 at TD CowenMarketBeatNYSE:KVYORead Klaviyo (NYSE:KVYO) Price Target Raised to $46.00 at TD Cowen2 hours agoHinge Health (NYSE:HNGE) Price Target Raised to $61.00 at Canaccord Genuity GroupMarketBeatNYSE:HNGERead Hinge Health (NYSE:HNGE) Price Target Raised to $61.00 at Canaccord Genuity Group2 hours agoFranklin BSP Realty Trust (NYSE:FBRT) Given New $13.00 Price Target at Jones TradingMarketBeatNYSE:FBRTRead Franklin BSP Realty Trust (NYSE:FBRT) Given New $13.00 Price Target at Jones Trading2 hours agoCanaccord Genuity Group Cuts Edgewell Personal Care (NYSE:EPC) Price Target to $32.00MarketBeatNYSE:EPCRead Canaccord Genuity Group Cuts Edgewell Personal Care (NYSE:EPC) Price Target to $32.002 hours agoInnospec (NASDAQ:IOSP) Sets New 12-Month Low - Should You Sell?MarketBeatNASDAQ:IOSPRead Innospec (NASDAQ:IOSP) Sets New 12-Month Low - Should You Sell?2 hours agoPROCEPT BioRobotics (NASDAQ:PRCT) Sets New 12-Month Low - Should You Sell?MarketBeatNASDAQ:PRCTRead PROCEPT BioRobotics (NASDAQ:PRCT) Sets New 12-Month Low - Should You Sell?2 hours agoRHI Magnesita (LON:RHIM) Reaches New 1-Year Low - Should You Sell?MarketBeatLON:RHIMRead RHI Magnesita (LON:RHIM) Reaches New 1-Year Low - Should You Sell?2 hours agoTamarack Valley Energy (TSE:TVE) Sets New 12-Month High - Here's What HappenedMarketBeatTSE:TVERead Tamarack Valley Energy (TSE:TVE) Sets New 12-Month High - Here's What Happened2 hours agoKBC Group (OTCMKTS:KBCSY) Hits New 52-Week High - Here's WhyMarketBeatOTCMKTS:KBCSYRead KBC Group (OTCMKTS:KBCSY) Hits New 52-Week High - Here's Why2 hours agoSuntec Real Estate Investment Trust (OTCMKTS:SURVF) Hits New 1-Year High - What's Next?MarketBeatOTCMKTS:SURVFRead Suntec Real Estate Investment Trust (OTCMKTS:SURVF) Hits New 1-Year High - What's Next? Featured Articles and OffersBitcoin and Dividends: A Winning Combo in These 3 ETFsBy Nathan Reiff | August 2, 2025View Bitcoin and Dividends: A Winning Combo in These 3 ETFsA new rule goes live in July — and the banks are quietly crushing itFrom American Alternative(Ad)View A new rule goes live in July — and the banks are quietly crushing itGolden Cross Alert: 3 Stocks With Serious Upside PotentialBy Chris Markoch | July 31, 2025View Golden Cross Alert: 3 Stocks With Serious Upside PotentialRocket Lab Reports Next Week: Here’s What Investors Should KnowBy Ryan Hasson | August 1, 2025View Rocket Lab Reports Next Week: Here’s What Investors Should KnowAnalysts Make a Quantum Bet on D-Wave's Cryogenic Packaging By Nathan Reiff | August 4, 2025View Analysts Make a Quantum Bet on D-Wave's Cryogenic Packaging [No Brainer Gold Play]: “Show me a better investment.”From Golden Portfolio(Ad)View [No Brainer Gold Play]: “Show me a better investment.”Novo Nordisk Stock Sinks—But Is a Bottom Finally In?By Chris Markoch | August 5, 2025View Novo Nordisk Stock Sinks—But Is a Bottom Finally In?AMD Outperforming NVIDIA: What’s Behind It and Can It Continue?By Dan Schmidt | August 4, 2025View AMD Outperforming NVIDIA: What’s Behind It and Can It Continue? Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
